ClinicalTrials.Veeva

Menu

A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

Z

Zhejiang Zylox Medical Device

Status

Enrolling

Conditions

Peripheral Artery Disease

Treatments

Device: Drug eluting Balloon

Study type

Interventional

Funder types

Industry

Identifiers

NCT05415995
V1.1/2021-12-25

Details and patient eligibility

About

This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.

Full description

This trail is conducted in several centers all around China. 202 subjects with below the knee arterial stenosis or occlusion will be recruited and randomized, this trail compares the efficacy and safety of Drug-coated Balloon (Zylox-Tonbridge) with a similar balloon catheter producted by Acotec. The subjects will be followed up when discharged /in 30 days/ 6 months.

Enrollment

202 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-85 years;
  • ≥70% diameter stenosis or occlusion in the target below-the-knee lesion;
  • Rutherford Category 3-6;
  • Subjects are willing to sign informed consent;

Exclusion criteria

  • Planned major limb amputation within 30 days after the procedure;
  • In-stent stenosis in the target lesion;
  • Severely calcified target lesions;
  • Creatinine>2.5mg/dL;
  • History of allergies to anesthetics, contrast agents;
  • Subjects who have participated in any other drug or medical device clinical investigations and haven't reach the primary endpoint;
  • Other circumstances judged by researchers that are not suitable for enrollment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

202 participants in 2 patient groups

101 Patients with Below The Knee Artery stenosis or occlusion in Experimental Group
Experimental group
Description:
Patients in this group use Drug eluting Balloon (Zylox-tonbridge), this is the product to be test in this clinical trail. The drug we coated is paclitaxel.
Treatment:
Device: Drug eluting Balloon
101 Patients with Below The Knee Artery stenosis or occlusion in Controlled Group
Active Comparator group
Description:
Patients in this group use Drug eluting Balloon(Acotec), this is a product that has got approved by NMPA in 2016.
Treatment:
Device: Drug eluting Balloon

Trial contacts and locations

20

Loading...

Central trial contact

Jie Liang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems